SPONSOR
Qilu Hospital of Shandong University
Total Trials
8
Recruiting
8
Phases
EARLY_Phase 1, Phase 4
Conditions studied: Post-Stroke Cognitive Impairment (PSCI)Repetitive Transcranial Magnetic Stimulation (rTMS)StrokeCranioplastyPostoperative ComplicationsRisk AssessmentBladder CancerCapsule EndoscopesEndometrial CancerMuscle Pain
Qilu Hospital of Shandong University is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Post-Stroke Cognitive Impairment (PSCI), Repetitive Transcranial Magnetic Stimulation (rTMS), Stroke, Cranioplasty.
The trial portfolio spans EARLY_Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Qilu Hospital of Shandong University
How many clinical trials has Qilu Hospital of Shandong University sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Qilu Hospital of Shandong University, of which 8 are actively recruiting participants. These trials cover conditions including Post-Stroke Cognitive Impairment (PSCI), Repetitive Transcranial Magnetic Stimulation (rTMS), Stroke. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Qilu Hospital of Shandong University research focus on?
Qilu Hospital of Shandong University clinical trials span Post-Stroke Cognitive Impairment (PSCI), Repetitive Transcranial Magnetic Stimulation (rTMS), Stroke, Cranioplasty, Postoperative Complications, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Qilu Hospital of Shandong University clinical trial?
To participate in a Qilu Hospital of Shandong University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Qilu Hospital of Shandong University trials with current recruitment status updated daily.
Clinical Trials by Qilu Hospital of Shandong University
NCT07546877
Recruiting
High-Frequency Repetitive Transcranial Magnetic Stimulation for Cognitive Improvement in Patients With Post-Stroke Cognitive Impairment
Post-Stroke Cognitive Impairment (PSCI)
NCT06740773
Recruiting
Risk Factors for Complications After Cranioplasty
Cranioplasty
NCT07379281
Recruiting
Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology
Bladder Cancer
NCT06303960 EARLY_Phase 1
Recruiting
Cerebellar Deep Brain Stimulation or VNS for Chronic Post-stroke Motor Rehabilitation
Stroke
NCT05546346
Recruiting
Clinical Application of Wearable Magnet Tracking System for Capsule Endoscopes
Capsule Endoscopes
NCT06656949
Recruiting
Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
Endometrial Cancer
NCT07809542
Recruiting
Brain Network Characteristics of Pain Patients Based on Magnetoencephalography
Muscle Pain
NCT06699420 Phase 4
Recruiting
Qishenyiqi Dripping Pill for Coronary Microvascular Disease
Coronary Microvascular Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology